AzTrials
AzTrials

AnesthesiaExtub_LocaNCT06249659

Impact of Extubation Location After Surgery on Perioperative Times

An observational study of Anesthesia and Intubation, run by University Hospital, Clermont-Ferrand at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The additional time required to awaken a patient is one of the main reasons for not extubating him or her in the operating room (OR). Conversely, transferring an intubated patient to recovery room (RR), prolonging the duration of anesthesia and intubation, in a limited environment in human resources, may lead to… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anesthesia, Intubation, Surgery
What is being tested?
Extubation in operative room and Extubation in post anesthesia care unit
Type of treatment
Surgery or procedure
How many people
756 participants
Where
1 siteFrance
Study dates
1 Sep 2020to 1 Feb 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Any patient requiring endotracheal extubation after general anesthesia

Who may be able to join

  • Adult (older than 18 years old)
  • Patients admitted to any operative room of participating centre for a surgical or endoscopic procedure under general anaesthesia requiring endo-tracheal intubation
  • Subjects must be covered by public health insurance
  • Written informed consent from the patient or proxy (if present) before inclusion or once possible when patient has been included in a context of emergency.

Who cannot join

  • Patient extubated in intensive care unit
  • Patient extubated during on-call hours (because of a reduced number of medical and paramedical staff)
  • Patient extubated following cardiac surgery
  • Refusal of study participation or to pursue the study by the patient
  • Absence of coverage by the French statutory healthcare insurance system
  • Protected person

Trial locations and contacts

1 site in 1 country.

France1 site
  • Clermont-Ferrand University Hospital

    Clermont-Ferrand, 63000

Other trials in France

About this study

Official title: Impact of Extubation Location After Surgery on Perioperative Times. A Prospective Multicenter Observational Study. Extub_Loca Study

The additional time required to awaken a patient is one of the main reasons for not extubating him or her in the operating room (OR). Conversely, transferring an intubated patient to recovery room (RR), prolonging the duration of anesthesia and intubation, in a limited environment in human resources, may lead to increased complications' rates. Little is known about those time lengths and complications rates.

Read the detailed description

The additional time required to awaken a patient is one of the main reasons for not extubating him or her in the operating room (OR). Conversely, transferring an intubated patient to recovery room (RR), prolonging the duration of anesthesia and intubation, in a limited environment in human resources, may lead to increased complications' rates. Little is known about those time lengths and complications rates. The primary objective was to evaluate the additional OR occupancy time associated with awakening and extubation. Secondary objectives were to assess the rate of post-extubation complications and the need for ventilatory support. This was a prospective multicenter observational study involving intubated patients who underwent surgeries in the operating theatres of the Montpellier and Clermont-Ferrand university hospitals. Anesthesia teams were asked to complete a form including data related to the patient, surgical procedure, anesthesia procedure (induction and recovery) and the occurrence of any complications during the procedure. A multivariate analysis was conducted on the full cohort, using a propensity score (IPTW, inverse probability of treatment weighting) to account for imbalances between groups.

Being tested
Extubation in operative room, Extubation in post anesthesia care unit
Keywords
General anesthesia, Extubation, Intubation, Time, Complications
Medical subject headings
Respiratory Insufficiency, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Extubation in operative roomProcedure or surgery

    Extubation takes place in operative room

  • Extubation in post anesthesia care unitProcedure or surgery

    Extubation takes place in post anesthesia care unit

Study groups in NCT06249659
Study groupRoleWhat they receive
Extubation in operative roomPatients are extubated in operative room after the end of surgery
Receives: Procedure: Extubation in operative room
Extubation in post anesthesia care unitPatients are extubated in post anesthesia care unit, after transfer from operative room
Receives: Procedure: Extubation in post anesthesia care unit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Additional operative room occupancy time associated with awakening and extubation

    Time between dressing application (or end of procedure if there was no cutaneous effraction) and discharge from the OR

    Measured: From end of procedure until extubation, assessed up to 2 hours

Secondary outcomes (17)
  1. Time from the end of the surgical procedure (closure of surgical site and dressing placement) to extubation

    Time from the end of the surgical procedure (closure of surgical site and dressing placement) to extubation

    Measured: From end of procedure until extubation, assessed up to 2 hours

  2. Time from the end of anaesthesia drug administration to extubation

    Time from the end of anaesthesia drug administration to extubation

    Measured: From end of anesthesia drug administration until extubation, assessed up to 2 hours

  3. Time from the end of the surgical procedure to patient able to be transferred to the ward (as defined by an Aldrete score above 10)

    Time from the end of the surgical procedure to patient able to be transferred to the ward (as defined by an Aldrete score above or equal to 10). Aldrete's scoring system is a commonly used scale for determining when postsurgical patients can be safely discharged from the post-anesthesia care unit (PACU), generally to an hospital ward, or home. Modified Aldrete score ranges from 0 to 12.

    Measured: From end of procedure until discharge to surgical ward, assessed up to 6 hours

  4. Impact of sequencing of operating programme in the room concerned on extubation location

    Impact of sequencing of operating programme in the room concerned on extubation location

    Measured: From end of procedure until next procedure in the same room, assessed up to one day

  5. Incidence of oxygen support requirement_Day-1

    Oxygen support requirement on the first day post-extubation

    Measured: First postoperative day

  6. Reported post-operative pulmonary complications_Day7

    Reported post-operative pulmonary complications within the first 7 days after extubation (as defined as acute respiratory failure, atelectasis, pneumonia, bronchospasm, pulmonary embolism or cardiorespiratory arrest)

    Measured: Seven first postoperative days

  7. Oxygen therapy_PACU

    Use of any rescue oxygen therapy after extubation in post-anesthesia care unit

    Measured: From end of procedure until discharge to surgical ward, assessed up to 6 hours

  8. Hypotension_PACU

    Hypotension occurrence (as defined by a systolic blood pressure below 90 mmHg and/or a mean arterial pressure below 65 mmHg)

    Measured: From end of procedure until discharge to surgical ward, assessed up to 6 hours

  9. Bradycardia_PACU

    Bradycardia occurrence (as defined as a drop of cardiac frequency below 50 beats.min-1)

    Measured: From end of procedure until discharge to surgical ward, assessed up to 6 hours

  10. Hypoxemia_PACU

    Desaturation occurrence defined as a drop of SpO2 below 96% (15), either early (within 5 min post-extubation) or delayed

    Measured: From end of procedure until discharge to surgical ward, assessed up to 6 hours

  11. NMBA_PACU

    Presence of residual neuromuscular blockade as illustrated by train of four below 90%

    Measured: From end of procedure until discharge to surgical ward, assessed up to 6 hours

  12. Reversal_NMBA

    Incidence of pharmacologic reversal of neuromuscular blocking agents

    Measured: From end of anesthesia until extubation, assessed up to 2 hours

  13. Loco-regional anaesthetic technique

    Use of any loco-regional anaesthetic technique

    Measured: Perioperative

  14. Drugs_neuromuscular blocking agents

    Use of neuromuscular blocking agents during anesthesia

    Measured: Perioperative

  15. Drugs_opioids

    Use of opioids during anesthesia

    Measured: Perioperative

  16. Drugs_hypnotics

    Use of hypnotics during anesthesia

    Measured: Perioperative

  17. Drugs_adjuvant analgesics

    Use of adjuvant analgesics during anesthesia

    Measured: Perioperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2024
  2. Study start1 Sep 2020
  3. Primary completion28 Jan 2023
  4. Study completion1 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
756 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06249659
Sponsor's protocol ID
IRB-MTP_2022_04_202201100
Acronym
Extub_Loca
Status last verified
Jan 2024
First submitted
4 Jan 2024
Last updated
8 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Available upon reasonable request after evaluation of research question

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia and Intubation, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Additional operative room occupancy time associated with awakening and extubation (time frame: From end of procedure until extubation, assessed up to 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in